Pleasanton, CA, United States of America

Theodore Charles Lamson

This inventor holds 94 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 16 EPO patents, primarily in Medical Devices (CPC class A61B17-0401). Top assignees: Neotract, Inc., Medtronic Vascular, Inc., Acclarent, Inc.. Active years: 2002-2025.

USPTO Granted Patents = 94 

% Patents Active = 86.2

 

 

Average Co-Inventor Count = 6.1

ph-index = 43

Forward Citations = 10,631(Granted Patents)

Forward Citations (Not Self Cited) = 9,608(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Pleasonton, CA (US) (2007)
  • Pleaston, CA (US) (2014)
  • Pleasanton, CA (US) (2002 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Benign Prostatic Hyperplasia
Anchor Delivery System
Tissue Manipulation
Microcatheter Devices
Retracting Apparatus
Expandable Tissue Engagement
Latching Anchor Device
Cerebrospinal Venous Insufficiency
Multi-Actuating Trigger
Incontinence Treatment
Flexible Delivery System
Ear Nose Throat Disorders
94 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Theodore Charles Lamson

Introduction: Theodore Charles Lamson, hailing from Pleasanton, CA, has made significant strides in the field of medical technology with an impressive portfolio of 92 patents. His work primarily focuses on devices and systems aimed at improving patient health outcomes, particularly in urology and vascular applications.

Latest Patents: Lamson's recent patents showcase his commitment to addressing complex medical issues. Among his notable inventions is a system for treating benign prostatic hyperplasia and other related conditions. This device encompasses methods for compressing, cutting, and altering anatomical structures to improve fluid flow through body lumens. This innovation is particularly beneficial for limiting urethra constriction caused by an enlarged prostate. Another noteworthy patent is the expandable tissue engagement apparatus, designed to manipulate prostate tissue effectively, enhancing medical treatment capabilities for various diseases and disorders.

Career Highlights: Throughout his career, Lamson has been affiliated with key players in the medical industry, including Neotract, Inc. and Medtronic Vascular, Inc. His work in these organizations has been pivotal in the development and commercialization of cutting-edge medical technologies.

Collaborations: Collaboration has been a cornerstone of Lamson's journey. He has worked alongside accomplished individuals in the field, including Joseph Catanese, III and Joshua Makower. Their combined expertise has undoubtedly contributed to the advancement of their shared goals in medical innovation.

Conclusion: Theodore Charles Lamson stands as a prominent figure in medical innovation, with his extensive list of patents underscoring his impact on healthcare technology. His dedication to improving health outcomes through innovative solutions continues to inspire the next generation of inventors and medical professionals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…